BioSource purchases European diagnostics assets
This article was originally published in Clinica
Executive Summary
US diagnostics manufacturer BioSource International has acquired the in vitro business of Medgenix Diagnostics in Belgium. Medgenix is a subsidiary of Canadian radioisotopes producer Nordion International. BioSource will pay $6.6 million in cash and royalties on certain Medgenix products for five years.